Suppr超能文献

Toll 样受体在原代气道上皮细胞中的表达及其诱导 I 型和 III 型干扰素。

Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells.

机构信息

The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.

出版信息

J Virol. 2013 Mar;87(6):3261-70. doi: 10.1128/JVI.01956-12. Epub 2013 Jan 9.

Abstract

Interferons (IFNs) are a critical component of the first line of antiviral defense. The activation of Toll-like receptors (TLRs) expressed by dendritic cells triggers different signaling cascades that result in the production of large amounts of IFNs. However, the functional consequences of TLR activation and differential IFN production in specific cell populations other than antigen-presenting cells have not yet been fully elucidated. In this study, we investigated TLR expression and polarization in airway epithelial cells (AECs) and the consequences of TLR agonist stimulation for the production of type I (IFN-α/β) and type III (IFN-λ) IFNs. Our results show that the pattern of expression and polarization of all TLRs in primary AEC cultures mirrors that of the human airways ex vivo and is receptor specific. The antiviral TLRs (TLR3, TLR7, and TLR9) are mostly expressed on the apical cell surfaces of epithelial cells in the human trachea and in primary polarized AECs. Type III IFN is the predominant IFN produced by the airway epithelium, and TLR3 is the only TLR that mediates IFN production by AECs, while all TLR agonists tested are capable of inducing AEC activation and interleukin-8 production. In response to influenza virus infection, AECs can produce IFN-λ in an IFNAR- and STAT1-independent manner. Our results emphasize the importance of using primary well-differentiated AECs to study TLR and antiviral responses and provide further insight into the regulation of IFN production during the antiviral response of the lung epithelium.

摘要

干扰素 (IFNs) 是抗病毒防御的第一道防线的关键组成部分。树突状细胞表达的 Toll 样受体 (TLRs) 的激活触发了不同的信号级联反应,导致大量 IFN 的产生。然而,TLR 激活和 IFN 产生在除抗原呈递细胞以外的特定细胞群体中的功能后果尚未完全阐明。在这项研究中,我们研究了气道上皮细胞 (AEC) 中 TLR 的表达和极化,以及 TLR 激动剂刺激对 I 型 (IFN-α/β) 和 III 型 (IFN-λ) IFN 产生的影响。我们的结果表明,原代 AEC 培养物中所有 TLR 的表达和极化模式与人体气道的 ex vivo 模式相吻合,并且是受体特异性的。抗病毒 TLRs (TLR3、TLR7 和 TLR9) 主要表达在人气管和原代极化 AEC 的上皮细胞的顶端细胞表面。III 型 IFN 是气道上皮细胞产生的主要 IFN,TLR3 是唯一介导 AEC IFN 产生的 TLR,而所有测试的 TLR 激动剂都能够诱导 AEC 激活和白细胞介素-8 产生。在流感病毒感染后,AEC 可以以 IFNAR 和 STAT1 非依赖性的方式产生 IFN-λ。我们的结果强调了使用原代分化良好的 AEC 来研究 TLR 和抗病毒反应的重要性,并提供了进一步深入了解肺上皮细胞抗病毒反应中 IFN 产生的调节。

相似文献

1
Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells.
J Virol. 2013 Mar;87(6):3261-70. doi: 10.1128/JVI.01956-12. Epub 2013 Jan 9.
2
An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity.
J Immunol. 2008 Feb 15;180(4):2474-85. doi: 10.4049/jimmunol.180.4.2474.
4
Extracellular Nucleotides and Histamine Suppress TLR3- and RIG-I-Mediated Release of Antiviral IFNs from Human Airway Epithelial Cells.
J Immunol. 2022 May 15;208(10):2390-2402. doi: 10.4049/jimmunol.2101085. Epub 2022 Apr 22.
6
Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
J Allergy Clin Immunol. 2006 Dec;118(6):1357-62. doi: 10.1016/j.jaci.2006.08.006. Epub 2006 Sep 25.
10
TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
Int Immunopharmacol. 2007 Aug;7(8):1111-21. doi: 10.1016/j.intimp.2007.04.006. Epub 2007 May 4.

引用本文的文献

1
Host Immune Response to Respiratory Syncytial Virus Infection in Children.
Influenza Other Respir Viruses. 2025 Sep;19(9):e70156. doi: 10.1111/irv.70156.
3
Lassa Virus Infection of Primary Human Airway Epithelial Cells.
Viruses. 2025 Apr 22;17(5):592. doi: 10.3390/v17050592.
4
Mucosal Immunity: Lessons from the Lower Respiratory and Small Intestinal Epithelia.
Biomedicines. 2025 Apr 26;13(5):1052. doi: 10.3390/biomedicines13051052.
5
A ventilated perfused lung model platform to dissect the response of the lungs to viral infection.
Trends Biotechnol. 2025 Jul;43(7):1714-1742. doi: 10.1016/j.tibtech.2025.03.012. Epub 2025 Apr 24.
6
Lung immune challenge study protocol: controlled exposure to inhaled resiquimod (R848) to study mechanisms of inflammation.
Immunother Adv. 2025 Feb 24;5(1):ltaf005. doi: 10.1093/immadv/ltaf005. eCollection 2025.
7
Human long noncoding RNA is induced by major respiratory viral infections and modulates the host interferon response.
J Virol. 2025 Apr 15;99(4):e0014125. doi: 10.1128/jvi.00141-25. Epub 2025 Mar 25.
8
Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapy.
Signal Transduct Target Ther. 2025 Mar 19;10(1):90. doi: 10.1038/s41392-025-02174-2.
9
Revisiting the Immunometabolic Basis for the Metabolic Syndrome from an Immunonutritional View.
Biomedicines. 2024 Aug 12;12(8):1825. doi: 10.3390/biomedicines12081825.
10
The RNA helicase DHX35 functions as a co-sensor for RIG-I-mediated innate immunity.
PLoS Pathog. 2024 Jul 22;20(7):e1012379. doi: 10.1371/journal.ppat.1012379. eCollection 2024 Jul.

本文引用的文献

1
Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection.
J Virol. 2012 May;86(10):5422-36. doi: 10.1128/JVI.06757-11. Epub 2012 Mar 7.
2
Induction and function of type I and III interferon in response to viral infection.
Curr Opin Virol. 2011 Dec;1(6):476-86. doi: 10.1016/j.coviro.2011.11.001.
3
Type I interferon response to extracellular bacteria in the airway epithelium.
Trends Immunol. 2011 Dec;32(12):582-8. doi: 10.1016/j.it.2011.09.003. Epub 2011 Oct 11.
4
Activation of the NLRP3 inflammasome by intracellular poly I:C.
FEBS Lett. 2010 Nov 19;584(22):4627-32. doi: 10.1016/j.febslet.2010.10.036. Epub 2010 Oct 23.
5
Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.
J Virol. 2010 Nov;84(21):11515-22. doi: 10.1128/JVI.01703-09. Epub 2010 Aug 25.
6
Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome?
Am J Respir Cell Mol Biol. 2011 Apr;44(4):465-73. doi: 10.1165/rcmb.2009-0453OC. Epub 2010 Jun 4.
7
8
Intracellular toll-like receptors.
Immunity. 2010 Mar 26;32(3):305-15. doi: 10.1016/j.immuni.2010.03.012.
9
Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection.
Infect Immun. 2010 Apr;78(4):1700-10. doi: 10.1128/IAI.00736-09. Epub 2010 Feb 1.
10
Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer.
Immunity. 2009 Dec 18;31(6):873-84. doi: 10.1016/j.immuni.2009.09.018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验